Fast and accurate insights into the behavior of new drugs

TRACER accelerate drug development through advanced techniques within phase 0 first in-human clinical trials. TRACER supports new drug developers by providing faster data access by using fluorescence and microdosing. This allows for quantifying the biodistribution and pharmacokinetics. This reduces the costs of potentially expensive follow-up studies.

Why we’re investing in TRACER

TRACER’s solution enables new drug development processes to be completed faster and more cost-effectively. Additionally, it leads to quicker selection of candidates for further study. The TRACER team consists of experienced, highly regarded experts and has already attracted several major pharmaceutical companies as clients.

Start a conversation
Start a conversation

Let’s team up

for impact

Partner up